Amdocs Limited

As of June 30, 2026, Amdocs Limited carries a market capitalization of 109.94B, placing it among publicly traded companies globally. Its enterprise value stands at 126.04B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Amdocs Limited's next confirmed earnings release is scheduled for November 17, 2026.

As of June 30, 2026, Amdocs Limited has 104.41M shares outstanding.

As of June 30, 2026, Amdocs Limited trades at a trailing price-to-earnings ratio of 14.20. The price-to-sales ratio is 1.38, and the price-to-book ratio stands at 1.91.

As of June 30, 2026, Amdocs Limited trades at an EV/EBITDA multiple of 8.63 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 1.55 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 11.51 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. Amdocs Limited trades at an EV/FCF ratio of 9.18, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 126.04B versus a market cap of 109.94B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Amdocs Limited maintains a current ratio of 0.94, meaning it holds 0.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 32.67, indicating elevated leverage, while an interest coverage ratio of 17.72 demonstrates strong ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Amdocs Limited posted a return on equity (ROE) of 13.37, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 11.12 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 7.12, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 11.07, useful for judging operating efficiency across full business cycles. The company generates approximately 3.01M in revenue per employee across its workforce of 26,969.00, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Amdocs Limited recorded 2.20B in income tax expense. That works out to an effective tax rate of 21.59, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 10.20B, leaving 7.93B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on August 21, 2026, Amdocs Limited's stock has declined approximately 27.91% over the past 52 weeks.

Over the twelve months ended June 30, 2026, Amdocs Limited generated 81.30B in revenue and converted that into 7.93B in net income, yielding earnings per share of 73.73. EBITDA reached 14.60B, while operating income came in at 14.48B.

As of June 30, 2026, Amdocs Limited holds 3.61B in cash and equivalents against 18.99B in total debt, resulting in a net debt position of 12.60B. Total book value stands at 57.42B, with working capital of -1.92B providing operational flexibility.

Amdocs Limited produced 13.08B in operating cash flow over the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Amdocs Limited posted a gross margin of 38.28, reflecting its pricing power and cost economics. The operating margin of 17.81 and net profit margin of 9.75 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, Amdocs Limited paid dividends of 37.95 per share. The dividend payout ratio of 50.36 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 11.46, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 8.70, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Amdocs Limited shareholders.